THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug under watch for rare blood disorder
Disease control Recruiting nowThis study is monitoring the safety and effectiveness of the drug ADZYNMA in patients with congenital Thrombotic Thrombocytopenic Purpura (cTTP), a rare and serious blood clotting disorder. It will observe about 40 patients in Japan for 18 months to track any side effects and see…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Landmark study tracks 1,200 survivors of deadly blood clotting disease
Knowledge-focused Recruiting nowThis study aims to understand the long-term health of people who have survived a rare and life-threatening blood clotting disorder called immune thrombotic thrombocytopenic purpura (iTTP). Researchers will look back at the medical records of over 1,200 patients in France to learn…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC